M
Malini B. DeSilva
Researcher at HealthPartners
Publications - 61
Citations - 2773
Malini B. DeSilva is an academic researcher from HealthPartners. The author has contributed to research in topics: Medicine & Vaccination. The author has an hindex of 10, co-authored 23 publications receiving 551 citations.
Papers
More filters
Journal ArticleDOI
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration - United States, 2020.
Jeanne M. Santoli,Megan C. Lindley,Malini B. DeSilva,Elyse O. Kharbanda,Matthew F. Daley,Lisa Galloway,Julianne Gee,Mick Glover,Ben Herring,Yoonjae Kang,Paul Lucas,M Cameron Noblit,Jeanne Tropper,Tara M. Vogt,Eric Weintraub +14 more
TL;DR: On March 13, 2020, the president of the United States declared a national emergency in response to the coronavirus disease 2019 (COVID-19) pandemic, and on March 24, CDC posted guidance emphasizing the importance of routine well child care and immunization, particularly for children aged ≤24 months, when many childhood vaccines are recommended.
Journal ArticleDOI
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
Jill M. Ferdinands,S. Rao,Brian E. Dixon,Patrick K. Mitchell,Malini B. DeSilva,Stephanie A. Irving,Ned Lewis,Karthik Natarajan,Edward Stenehjem,Shaun J. Grannis,Jungmi Han,Charlene McEvoy,Toan C. Ong,Allison L. Naleway,Sara E. Reese,Peter J. Embi,Kristin Dascomb,Nicola P. Klein,E. Griggs,D. Konatham,Anupam B. Kharbanda,Duck-Hye Yang,William F. Fadel,Nancy Grisel,Kristin Goddard,Palak Patel,I-Chia Liao,Rebecca Birch,Nimish Valvi,Sue Reynolds,Julie Arndorfer,Ousseny Zerbo,M. Dickerson,Kempapura Murthy,Jeremiah Williams,Catherine H Bozio,Lenee Blanton,Jennifer R. Verani,Stephanie J. Schrag,Alexandra F. Dalton,Mehiret Wondimu,Ruth Link-Gelles,Eduardo Azziz-Baumgartner,Michelle A. Barron,Manjusha Gaglani,Mark Thompson,Bruce Fireman +46 more
TL;DR: VE after receipt of a third dose was higher than that after a second dose; however, VE waned with increasing time since vaccination, and VE was generally higher for protection against hospitalizations than against ED/UC visits.
Journal ArticleDOI
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
Mark G. Thompson,Edward Stenehjem,Shaun J. Grannis,Sarah Ball,Allison L. Naleway,Toan C. Ong,Malini B. DeSilva,Karthik Natarajan,Catherine H Bozio,Ned Lewis,Kristin Dascomb,Brian E. Dixon,Rebecca J. Birch,Stephanie A. Irving,Suchitra Rao,Elyse O. Kharbanda,Jungmi Han,Sue Reynolds,Kristin Goddard,Nancy Grisel,William F. Fadel,Matthew E Levy,Jill M. Ferdinands,Bruce Fireman,J.A Arndorfer,Nimish R. Valvi,Elizabeth A Rowley,Palak Patel,Ousseny Zerbo,Eric P. Griggs,Rachael M. Porter,Maria Demarco,Lenee Blanton,Andrea Steffens,Yan Zhuang,Natalie Olson,Michelle A. Barron,Pat Shifflett,Stephanie J. Schrag,Jennifer R. Verani,Alicia M Fry,Manjusha Gaglani,Eduardo Azziz-Baumgartner,Nicola P. Klein +43 more
TL;DR: In this article, the effectiveness of the Ad26.COV2.S vaccine against SARS-CoV-2 infection requiring hospitalization, ICU admission, or an emergency department or urgent care clinic visit was evaluated.
Journal ArticleDOI
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
Mark Thompson,Karthik Natarajan,Stephanie A. Irving,Elizabeth Rowley,E. Griggs,Manjusha Gaglani,Nicola P. Klein,Shaun J. Grannis,Malini B. DeSilva,Edward Stenehjem,Sara E. Reese,M. Dickerson,Allison L. Naleway,Jungmi Han,D. Konatham,Charlene McEvoy,S. Rao,Brian E. Dixon,Kristin Dascomb,Ned Lewis,M. Levy,Palak Patel,I-Chia Liao,Anupam B. Kharbanda,Michelle A. Barron,William F. Fadel,Nancy Grisel,Kristin Goddard,Duck-Hye Yang,Mehiret Wondimu,Kempapura Murthy,Nimish Valvi,Julie Arndorfer,Bruce Fireman,M. Dunne,Peter J. Embi,Eduardo Azziz-Baumgartner,Ousseny Zerbo,Catherine H Bozio,Sue Reynolds,Jill M. Ferdinands,Jeremiah Williams,Ruth Link-Gelles,Stephanie J. Schrag,Jennifer R. Verani,Sarah Ball,Toan C. Ong +46 more
TL;DR: The highest estimates of VE against COVID-19-associated ED and UC encounters or hospitalizations during both Delta- and Omicron-predominant periods were among adults who received a third dose of mRNA vaccine, and all unvaccinated persons should get vaccinated as soon as possible.
Journal ArticleDOI
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022
Nicola P. Klein,Melissa S. Stockwell,Maria Demarco,Manjusha Gaglani,Anupam B. Kharbanda,Stephanie A. Irving,S. Rao,Shaun J. Grannis,Kristin Dascomb,Kempapura Murthy,Elizabeth Rowley,Alexandra F. Dalton,Malini B. DeSilva,Brian E. Dixon,Karthik Natarajan,Edward Stenehjem,Allison L. Naleway,Ned Lewis,Toan C. Ong,Palak Patel,D. Konatham,Peter J. Embi,Sara E. Reese,Jungmi Han,Nancy Grisel,Kristin Goddard,Michelle A. Barron,M. Dickerson,I-Chia Liao,William F. Fadel,Duck-Hye Yang,Julie Arndorfer,Bruce Fireman,E. Griggs,Nimish Valvi,C. Hallowell,Ousseny Zerbo,Sue Reynolds,Jill M. Ferdinands,Mehiret Wondimu,Jeremiah Williams,Catherine H Bozio,Ruth Link-Gelles,Eduardo Azziz-Baumgartner,Stephanie J. Schrag,Mark Thompson,Jennifer R. Verani +46 more
TL;DR: VE against laboratory-confirmed COVID-19-associated hospitalization among children aged 5-11 years was 74% 14-67 days after dose 2, with wide CIs that included zero, and in adolescents aged 16-17 years, VE during the Omicron predominant period increased to 81% ≥7 days after a third booster dose.